| Literature DB >> 35022000 |
Nigul Ilves1,2, Silva Lõo3,4, Norman Ilves5,6, Rael Laugesaar4,7, Dagmar Loorits5, Pille Kool6, Tiina Talvik7, Pilvi Ilves5,6.
Abstract
BACKGROUND: Perinatal stroke (PS) is the leading cause of hemiparetic cerebral palsy (CP). Involvement of the corticospinal tract on neonatal magnetic resonance imaging (MRI) is predictive of motor outcome in patients with hemiparetic CP. However, early MRI is not available in patients with delayed presentation of PS and prediction of hemiparesis severity remains a challenge. AIMS: To evaluate the volumes of the basal ganglia, amygdala, thalamus, and hippocampus following perinatal ischemic stroke in relation to hand motor function in children with a history of PS and to compare the volumes of subcortical structures in children with PS and in healthy controls.Entities:
Keywords: Basal ganglia; MRI; Motor outcome; Perinatal stroke; Thalamus; Volumetrics
Mesh:
Year: 2022 PMID: 35022000 PMCID: PMC8753896 DOI: 10.1186/s12883-022-02550-3
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Demographics of the study groups
| Demographics | AIS | PVI | Control | |
|---|---|---|---|---|
| Sex Boys/girls | 8/8 | 7/11 | 24/18 | 0.429 # |
| Side of stroke (MRI) left; n (%) | 12 (75%) | 12 (66.7%) | 0.715 * | |
| Age (years) at MRI; mean (95% CI), [range] | 11.39 (9.47–13.31) [4.86–17.15] | 10.38 (9.04–11.73) [6.78–15.86] | 11.59 (10.79–12.39) [8.07–17.86] | 0.253 $ |
| AIS classification | ||||
| Proximal M1 of the MCA; n (%) | 4 (25%) | |||
| Distal M1 of the MCA; n (%) | 5 (31.25%) | |||
| Anterior trunk; n (%) | 3 (18.75%) | |||
| Posterior trunk; n (%) | 4 (25%) | |||
| Age (years) at AHA; mean (95% CI), [range] | 8.47 (6.93–10.00) [4.6–13.2] | 7.45 (6.18–8.73) [3.5–12.7] | 0.208 & | |
| AHA unit; mean (95% CI) | 58.56 (48.63–68.50) | 64.22 (58.1–70.27) | 0.297 § | |
| Right sensorimotor deficit (according to PSOM) | 0.272 * | |||
| Normal; n (%) | 1 (6.3%) | 0 (0%) | ||
| Mild; n (%) | 4 (25%) | 1 (5.6%) | ||
| Moderate; n (%) | 4 (25%) | 8 (44.4%) | ||
| Severe; n (%) | 7 (43.8%) | 9 (50.0%) | ||
| PSOM; median (IQR), [range] | 2.0 (1.5–2.75) [0.5–7.0] | 2.0 (1.0–3.0) [0.5–5.0] | 0.713 & | |
| MACS | 0.348 * | |||
| MACS level I; n (%) | 6 (37.5%) | 5 (27.8%) | 0.545 ‡ # | |
| MACS level II; n(%) | 3 (18.8%) | 8 (44.4%) | ||
| MACS level III; n (%) | 6 (37.5%) | 5 (27.8%) | ||
| MACS level IV; n (%) | 1 (6.3%) | 0 (0%) | ||
Abbreviations: n number of patients, CI confidence interval, IQR interquartile range
# Chi-square; * Fisher’s exact; $ ANOVA; & Wilcoxon-Mann-Whitney; § t-test; ‡ Reference group: patients with MACS levels II, III or IV
Fig. 1The results of FSLVBM (voxel based morphometry) revealing significant differences in gray matter volume Control>AIS (a), AIS > Control (b), Control>PVI (c, d). All images show tfce (threshold-free cluster enhancement) and FWE (family-wise error) corrected t-stats (1-p) > 0.95 with MNI coordinates indicated. Differences in the thalamus and nucleus caudatus for both AIS and PVI (a, c, d); putamen and cortex in (a) and motor cortex in (c) are presented
Volumes of normalized subcortical brain structures with between-groups comparisons
| Structure normalized [mm3] | Control | AIS | PVI | Control-AIS | Control-PVI | AIS-PVI |
|---|---|---|---|---|---|---|
Scaling factor for head size; mean (95% CI) | 1.38 (1.34–1.41) | 1.47 (1.40–1.55) | 1.51 (1.45–1.57) | 0.369 | ||
| Range of scaling factor | 1.15–1.62 | 1.26–1.69 | 1.32–1.69 | |||
Thalamus, ipsilesional; median (IQR)a | 11,548 (10930–11,948) | 9154 (5487–10,017) | 9177 (8355–10,069) | 0.617 | ||
Thalamus, contralesional; mean (95% CI) | 11,009 (10787–11,230) | 10,312 (9872–10,752) | 10,676 (10257–11,095) | 0.128 | 0.171 | |
Caudate nucleus, ipsilesional; mean (95% CI) | 5694 (5499–5889) | 4905 (4083–5727) | 4768 (4283–5252) | 0.064 | 0.756 | |
Caudate nucleus, contralesional; mean (95% CI) | 5861 (5684–6037) | 5915 (5433–6397) | 5770 (5416–6123) | 0.787 | 0.638 | 0.537 |
Putamen, ipsilesional; median (IQR)a | 7355 (6979–7911) | 6332 (4198–7756) | 7103 (5981–7496) | 0.048 | 0.083 | 0.523 |
Putamen, contralesional; mean (95% CI) | 7326 (7130–7522) | 7851 (7355–8348) | 7217 (6889–7544) | 0.050 | 0.545 | 0.027 |
Globus pallidus, ipsilesional; median (IQR)a | 2443 (2331–2535) | 2138 (1646–2346) | 2231 (2099–2356) | 0.277 | ||
Globus pallidus, contralesional; mean (95% CI) | 2501 (2443–2558) | 2465 (2318–2612) | 2540 (2397–2683) | 0.633 | 0.600 | 0.444 |
Hippocampus, ipsilesional; median (IQR)a | 5265 (4994–5451) | 4422 (3875–5049) | 4862 (4540–5283) | 0.125 | ||
Hippocampus, contralesional; mean (95% CI) | 5293 (5141–5445) | 5379 (5044–5714) | 5210 (4933–5486) | 0.586 | 0.583 | 0.361 |
Amygdala, ipsilesional, mean (95% CI) | 1610 (1504–1716) | 1421 (1212–1629) | 1537 (1377–1697) | 0.068 | 0.458 | 0.334 |
Amygdala, contralesional; mean (95% CI) | 1540 (1454–1626) | 1554 (1365–1743) | 1562 (1416–1709) | 0.877 | 0.796 | 0.936 |
Nucleus accumbens, ipsilesional; mean (95% CI) | 756 (711–801) | 524 (416–633) | 701 (601–802) | 0.268 | ||
Nucleus accumbens, contralesional; median (IQR)a | 593 (534–692) | 631 (477–705) | 611 (523–686) | 0.924 | 0.790 | 0.904 |
Subcortical brain structures segmented using the FSL’s FIRST tool and the volumes normalized by the FSL’s SIENAX tool’s volumetric scaling factor in mm3. Abbreviations: CI Confidence interval, IQR interquartile range. Between-groups comparison, using ANOVA or Kruskal-Wallis test (in absence of normal distribution denoted by with a). After FDR correction, using level 0.05, the cutoff p-value for significance of a single comparison was 0.033
Correlation of AHA units with normalized subcortical brain structure
| Structure | AIS | PVI | ||
|---|---|---|---|---|
| r | p | r | p | |
| Scaling factor for head size | −0.60 | −0.30 | 0.231 | |
| Thalamus, ipsilesional | 0.66 | 0.83 a | ||
| Thalamus, contralesional | −0.11 | 0.680 | 0.57 | |
| Caudate nucleus, ipsilesional | 0.35 | 0.179 | 0.62 | |
| Caudate nucleus, contralesional | −0.47 | 0.065 | −0.01 | 0.958 |
| Putamen, ipsilesional | 0.55 | 0.20 | 0.428 | |
| Putamen, contralesional | −0.57 | −0.25 | 0.310 | |
| Globus pallidus, ipsilesional | 0.59 | 0.46 a | 0.053 | |
| Globus pallidus, contralesional | 0.09 | 0.748 | 0.09 | 0.709 |
| Hippocampus, ipsilesional | 0.51 a | 0.16 | 0.527 | |
| Hippocampus, contralesional | −0.53 | −0.01 | 0.981 | |
| Amygdala, ipsilesional | 0.59 a | 0.30 | 0.230 | |
| Amygdala, contralesional | 0.62 | −0.14 | 0.579 | |
| Nucleus accumbens, ipsilesional | 0.41 | 0.111 | 0.18 | 0.463 |
| Nucleus accumbens, contralesional | 0.42 | 0.104 | −0.17 | 0.496 |
Volumes normalized by head size using the FSL’s SIENAX tool volumetric scaling factor. Pearson’s correlation coefficient is provided in case the assumptions of the linear regression model are satisfied. When these assumptions are not satisfied, Spearman’s rank correlation coefficient is provided and noted by a. After FDR correction, using level 0.08, the cutoff p-value for significance of a single comparison was 0.048 (for the AIS group) and 0.016 (for the PVI group) marked in bold
Fig. 2Statistically significant linear correlations between affected hand function, based on AHA test, and volume of the subcortical structures for children with AIS and PVI. (a) subject’s head size measured by using FSL’s SIENAX tool’s volumetric scaling factor, (b) ipsilesional caudate nucleus, (c) contralesional thalamus, (d) ipsilesional thalamus, (e) ipsilesional putamen, (f) Ipsilesional globus pallidus, (g) contralesional putamen, (h) contralesional hippocampus, (i) contralesional amygdala
Comparison of normalized subcortical brain structure volumes in mm3 in AIS and PVI children at different bimanual motor outcome levels of the MACS scale
| Structure normalized [mm3] | AIS | PVI | ||||||
|---|---|---|---|---|---|---|---|---|
| MACS | I | II | III-IV | I | II | III-IV | ||
| mean (95% CI) or median (IQR)* | mean (95% CI) or median (IQR)* | mean (95% CI) or median (IQR)* | mean (95% CI) | mean (95% CI) | mean (95% CI) | |||
| Thalamus, ipsilesional | 9919 (8758–11,080) | 9945 (7865–12,025) | 5485 (2991–7980) | 10,649 (8721–12,577) | 9162 (8578–9746) | 6895 (4187–9603) | ||
| Thalamus, contralesional | 10,110 (9643–10,307)* | 10,237 (10227–11,289)* | 10,291 (9587–10,988)* | 0.861 * | 11,371 (10364–12,378) | 10,544 (9830–11,258) | 10,190 (9709–10,672) | 0.062 |
| Caudate nucleus, ipsilesional | 5266 (4345–6186) | 5872 (2560–9183) | 4182 (2449–5915) | 0.355 | 5416 (4205–6628) | 4801 (4218–5383) | 4067 (2769–5364) | 0.082 |
| Caudate nucleus, contralesional | 5506 (4761–6252) | 5987 (4539–7435) | 6235 (5211–7258) | 0.372 | 5664 (4678–6649) | 5825 (5178–6472) | 5787 (4954–6620) | 0.931 |
| Putamen, ipsilesional | 6778 (5926–7629) | 7242 (1967–12,518) | 4314 (1469–7159) | 0.248 | 7099 (5677–8522) | 6984 (6344–7624) | 6505 (5156–7855) | 0.590 |
| Putamen, contralesional | 7171 (6486–7856) | 8140 (5749–10,530) | 8311 (7508–9114) | 0.063 | 7007 (5952–8063) | 7185 (6764–7605) | 7476 (6569–8384) | 0.550 |
| Globus pallidus, ipsilesional | 2324 (2097–2551) | 2148 (974–3322) | 1459 (723–2194) | 0.122 | 2415 (2052–2778) | 2236 (2107–2365) | 1953 (1456–2451) | 0.055 |
| Globus pallidus, contralesional | 2469 (2209–2730) | 2606 (1657–3556) | 2400 (2147–2653) | 0.588 | 2575 (2145–3005) | 2604 (2373–2834) | 2403 (2082–2724) | 0.478 |
| Hippocampus, ipsilesional | 4831 (4252–5410) | 4911 (3044–6778) | 3881 (2874–4888) | 0.120 | 4680 (3787–5573) | 4960 (4631–5288) | 4619 (3518–5720) | 0.604 |
| Hippocampus, contralesional | 5095 (4516–5673) | 4828 (4233–5424) | 5858 (5431–6286) | 0.010 | 5140 (4560–5720) | 5193 (4652–5734) | 5306 (4573–6038) | 0.901 |
| Amygdala, ipsilesional | 1647 (1312–1983) | 1474 (1178–1770) | 1203 (805–1602) | 0.116 | 1567 (1229–1904) | 1602 (1307–1898) | 1402 (981–1824) | 0.565 |
| Amygdala, contralesional | 1705 (1381–2030) | 1679 (985–2374) | 1371 (1025–1716) | 0.196 | 1605 (1135–2074) | 1531 (1264–1799) | 1569 (1317–1821) | 0.918 |
| Nucleus accumbens, ipsilesional | 632 (439–825) | 584 (61–1108) | 407 (245–568) | 0.110 | 664 (451–877) | 786 (675–897) | 603 (243–963) | 0.306 |
| Nucleus accumbens, contralesional | 630 (501–759) | 703 (613–793) | 500 (349–651) | 0.093 | 572 (428–717) | 655 (534–777) | 601 (544–658) | 0.458 |
bold text = significant p-value after FDR correction (using level 0.05, the single comparison cutoff p-value being 0.0042 for the AIS and PVI groups);
# = mean volume difference between subjects with MACS I and III-IV;
$ = mean volume difference between subjects with MACS II and III-IV;
* = absence of normal distribution (Kruskal-Wallis test used instead of ANOVA)